Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Psychoneuroendocrinology. 2013 Sep 21;39:204–213. doi: 10.1016/j.psyneuen.2013.09.014

Figure 3.

Figure 3

Effects of intracerebroventricular abiraterone (ABI, 1 μg/μl) on startle reflex (A) and %PPI (B) in relation to the gating deficits induced by systemic apomorphine (APO, 0.25 mg/kg, SC). ABI doses are indicated in μg (in 1μl of solution). VEH, vehicle of ABI (Hydroxypropyl β-Cyclodextrin/Ringer solution, 20% w/v). Values are expressed as mean ± S.E.M, N= 8-9/group. *, P<0.05 vs rats treated with VEH and saline (pretreatment x treatment interaction); #, P<0.05 vs rats treated with VEH and APO. For further details, see text.